Page results
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
This page is for patients with obesity who are waiting for scheduled surgery.
-
Information for service users about the RESPOND service for refugees and asylum seekers.
-
Dr. Patrick Murphy is a principal clinical neuropsychologist at the National Hospital for Neurology and Neurosurgery
-
Our neonatal service is a recognised centre of excellence caring for acutely ill and preterm babies from our local area and beyond.
-
Acute loss of sense of smell should be considered globally as a criterion for self-isolation, testing, and contact tracing for Covid-19 infection according to researchers at UCLH and UCL.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
This page is for patients receiving steroids for immunotherapy toxicity.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
File results
-
FOI/2021/0651 - IT Pathology system
-
FOI/2021/0622 - Income generation - Cost Improvement Plans (CIP)
-
FOI/2021/0636 - Physician Associates
-
FOI/2021/0655 - Acute care provider collaborative
-
FOI/2021/0504 - Podiatry and orthotic services
-
FOI/2021/0370 - Deaths caused by care
-
FOI/2021/0191 - Recruitment data
-
FOI/2021/0091 - Patients admitted with respiratory conditions - SARS-COV-2
-
FOI/2021/0002 - Covid-19 deaths 01.02.2020 - 31.12.2020
-
FOI/2021/0602 - Chemotherapy units staffing treating adults with cancer